HealthCare Market Analysis

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t

The  Europe nutrition and supplements market  is expected to reach USD 52.9 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.9% during the forecast period. It is primarily driven by increasing awareness about healthy lifestyle, weight management, sports nutrition, healthy eating, and wellbeing. Growing geriatric population and surging healthcare costs in the region are among the key trends estimated to trigger market growth. Increasing health consciousness among consumers and rising willingness to spend on nutrition and dietary supplements are also projected to augur well for the growth of the market. Moreover, upswing in the number of distribution channels for nutraceuticals is poised to improve their accessibility, which will stimulate the growth of the market. Spiraling demand for nutraceuticals from consumers and growing emphasis on food content are also anticipated to escalate the growth of the market. In terms of age group

The global  cell culture market  is expected to reach USD 37.0 billion by 2022, according to a new report by Grand View Research, Inc. This expected growth in demand can be ascribed to the growing need for biopharmaceutical development, vaccine research and development, and protein production; all of which rely heavily on cytological R&D in which cell culture plays a pivotal role.  The development and commercialization of integrated robotic liquid handling laboratory automation culture systems is also expected to considerably enhance growth over the forecast period. These systems provide highly improved capacity handling, higher efficiency and reproducible purity levels.  Browse full research report on Cell Culture Market : www.grandviewresearch.com/industry-analysis/cell-culture-market                       Further key findings from the study suggest:                                                                         Cell culture sera account